(Q44299609)

1 December 2017

title

Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain (English)

1 reference

1 December 2017

0 references

Xia HH

1

1 reference

1 December 2017

Lai KC

2

1 reference

1 December 2017

Lam SK

3

1 reference

1 December 2017

Hu WH

4

1 reference

1 December 2017

Wong NY

5

1 reference

1 December 2017

Hui WM

6

1 reference

1 December 2017

Lau CP

7

1 reference

1 December 2017

Chen WH

8

1 reference

1 December 2017

Chan CK

9

1 reference

1 December 2017

Wong WM

10

1 reference

1 December 2017

Wong BC

11

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Alimentary Pharmacology & Therapeutics

1 December 2017

published in

1 reference

1 December 2017

volume

17

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

369-377

1 reference

Review article: the burden of illness of non-cardiac chest pain

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Contribution of central sensitisation to the development of non-cardiac chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

High dose proton pump inhibitor response as an initial strategy for a clinical diagnosis of gastro-oesophageal reflux disease (GERD). Swedish multi-centre group in primary health care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

The Hong Kong index of dyspepsia: a validated symptom severity questionnaire for patients with dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

A critical approach to noncardiac chest pain: pathophysiology, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

The diagnoses of patients admitted with acute chest pain but without myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Group psychological treatment for chest pain with normal coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Cognitive Change following Cognitive Behavioural Therapy for Non-Cardiac Chest Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Effect of omeprazole in patients with chest pain and normal coronary anatomy: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

Should noncardiac chest pain be treated empirically? A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01436.X

10.1046/J.1365-2036.2003.01436.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference